Evidence map›Paper›PMID 38744284›Full record

ArticleAmerican journal of human genetics2024

Missense variants in ANO4 cause sporadic encephalopathic or familial epilepsy with evidence for a dominant-negative effect.

Fang Yang, Anais Begemann, Nadine Reichhart, Akvile Haeckel, Katharina Steindl, Eyk Schellenberger, Ronja Fini Sturm, Magalie Barth, Sissy Bassani, Paranchai Boonsawat and 23 more

Abstract read
In one paragraph

Article in American journal of human genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Fang YangExperimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität, Humboldt-University, the Berlin Institute of Health, Berlin, Germany.
Anais BegemannInstitute of Medical Genetics, University of Zurich, Schlieren-Zurich, Switzerland.
Nadine ReichhartExperimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität, Humboldt-University, the Berlin Institute of Health, Berlin, Germany.
Akvile HaeckelInstitute for Radiology and Children's Radiology, Charité-Universitätsmedizin Berlin, a Corporate Member of Freie Universität, Humboldt-University, the Berlin Institute of Health, Berlin, Germany.
Katharina SteindlInstitute of Medical Genetics, University of Zurich, Schlieren-Zurich, Switzerland.
Eyk SchellenbergerInstitute for Radiology and Children's Radiology, Charité-Universitätsmedizin Berlin, a Corporate Member of Freie Universität, Humboldt-University, the Berlin Institute of Health, Berlin, Germany.
Ronja Fini SturmExperimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität, Humboldt-University, the Berlin Institute of Health, Berlin, Germany.
Magalie BarthUniversity Hospital of Angers, Department of Genetics, Angers, France.
Sissy BassaniInstitute of Medical Genetics, University of Zurich, Schlieren-Zurich, Switzerland.
Paranchai BoonsawatInstitute of Medical Genetics, University of Zurich, Schlieren-Zurich, Switzerland.
Thomas CourtinSorbonne Université, INSERM, CNRS, Institut du Cerveau - Paris Brain Institute - ICM, 75013 Paris, France; Hôpital Pitié-Salpêtrière, DMU BioGe'M, AP-HP, 75013 Paris, France.
Bruno DelobelService de Cytogénétique, GH de l'Institut Catholique de Lille, Hopital Saint Vincent de Paul, Lille, France.
EuroEPINOMICS-RES Dravet working group
Boudewijn GunningStichting Epilepsie Instellingen Nederland, Zwolle, the Netherlands.
Katia HardiesApplied & Translational Neurogenomics Group, VIB Center for Molecular Neurology, VIB, University of Antwerp, 2610 Antwerp, Belgium.
Mélanie JennessonDepartment of Pediatrics, CHU, Reims, France.
Louis LegoffUniversity Hospital of Angers, Department of Genetics, Angers, France.
Tarja LinnankiviEpilepsia Helsinki, University of Helsinki and Helsinki University Hospital, 00029 HUS Helsinki, Finland; Department of Pediatric Neurology and Pediatric Research Center, New Children's Hospital, Helsinki University Hospital and University of Helsinki, 00029 HUS Helsinki, Finland.
Clément ProuteauUniversity Hospital of Angers, Department of Genetics, Angers, France.
Noor SmalApplied & Translational Neurogenomics Group, VIB Center for Molecular Neurology, VIB, University of Antwerp, 2610 Antwerp, Belgium.
Marta SpodenkiewiczDepartment of Genetics, La Réunion University Hospital, Saint-Pierre, France.
Sandra P ToelleDepartment of Pediatric Neurology, Children's University Hospital Zurich, Zurich, Switzerland.
Koen Van GassenUniversity Medical Center Utrecht, Department of Genetics, Utrecht, the Netherlands.
Wim Van PaesschenLaboratory for Epilepsy Research, KU Leuven, and Neurology Department, University Hospitals Leuven, 3000 Leuven, Belgium.
Nienke VerbeekUniversity Medical Center Utrecht, Department of Genetics, Utrecht, the Netherlands.
Alban ZieglerUniversity Hospital of Angers, Department of Genetics, Angers, France.
Markus ZweierInstitute of Medical Genetics, University of Zurich, Schlieren-Zurich, Switzerland.
Anselm H C HornInstitute of Medical Genetics, University of Zurich, Schlieren-Zurich, Switzerland; Division of Bioinformatics, Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Heinrich StichtDivision of Bioinformatics, Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Holger LercheDepartment of Neurology and Epileptology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Sarah WeckhuysenApplied & Translational Neurogenomics Group, VIB Center for Molecular Neurology, VIB, University of Antwerp, 2610 Antwerp, Belgium; Department of Neurology, Antwerp University Hospital, Antwerp, Belgium; Translational Neurosciences, Faculty of Medicine and Health Science, University of Antwerp, 2610 Antwerp, Belgium.
Olaf StraußExperimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, a Corporate Member of Freie Universität, Humboldt-University, the Berlin Institute of Health, Berlin, Germany.
Anita RauchInstitute of Medical Genetics, University of Zurich, Schlieren-Zurich, Switzerland; Children's University Hospital Zurich, Zurich, Switzerland. Electronic address: anita.rauch@medgen.uzh.ch.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Anoctamins are a family of Ca

Indexed as

AnoctaminsMutation, MissenseAdolescentCalciumChildChild, PreschoolEpilepsyFemaleGenes, DominantGenetic Association StudiesHEK293 CellsHumansMalePedigreePhospholipid Transfer ProteinsANO4 protein, humanAnoctaminsCalciumPhospholipid Transfer ProteinsANO4anoctaminCa(2+)-dependent ion channeldevelopmental and epileptic encephalopathyGEFS+phospholipid scramblasetemporal lobe epilepsyTMEM16D

Identifiers

PMID38744284
PMCPMC11179416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.